Exact Mass: 463.2682

Exact Mass Matches: 463.2682

Found 49 metabolites which its exact mass value is equals to given mass value 463.2682, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Azd-4547

N-{5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl}-4-(3,5-dimethylpiperazin-1-yl)benzamide

C26H33N5O3 (463.2583)

Bucromarone

2-{4-[3-(dibutylamino)propoxy]-3,5-dimethylbenzoyl}-4H-chromen-4-one

C29H37NO4 (463.2722)

C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent

(13E,21E)-(7S,16R)-6,7-epoxy-16-methyl-10-phenyl-[14]cytochalasa-13,21-diene-1,23-dione

C29H37NO4 (463.2722)

(13E,21E)-(7S,16R,20R)-7,20-dihydroxy-16-methyl-10-phenyl-[14]-cytochalasa-5,13,21-triene-1,23-dione

C29H37NO4 (463.2722)

PA(19:3/0:0)

1-(10Z,13Z,16Z-nonadecatrienoyl)-sn-glycero-3-phosphate (Ammonium salt)

C22H42NO7P (463.2699)

PE(17:2(9Z,12Z)/0:0)

1-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphoethanolamine

C22H42NO7P (463.2699)

LPE 17:2

1-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphoethanolamine

C22H42NO7P (463.2699)

Azd-4547

C26H33N5O3 (463.2583)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor

UNC 2881

C25H33N7O2 (463.2696)

Valsartan Ethyl Ester

C26H33N5O3 (463.2583)

Valsartan Ethyl Ester is an impurity of Valsartan. Valsartan is an angiotensin II receptor antagonist for the treatment of high blood pressure and heart failure[1].

Bucromarone

C29H37NO4 (463.2722)

C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent

2-(2,4-dimethoxyanilino)-N-[3-(4-methyl-1-piperazinyl)propyl]-4-quinolinecarboxamide

C26H33N5O3 (463.2583)

3-[3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl-[1-(2-oxolanylmethyl)-5-tetrazolyl]methyl]-6-ethyl-1H-quinolin-2-one

C25H33N7O2 (463.2696)

3-[3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl-[1-(2-oxolanylmethyl)-5-tetrazolyl]methyl]-5,7-dimethyl-1H-quinolin-2-one

C25H33N7O2 (463.2696)

(8S,9S,10S)-9-[4-(1-cyclohexenyl)phenyl]-N-(2-fluorophenyl)-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C28H34FN3O2 (463.2635)

(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propyl-1-(3-pyridinylmethyl)-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide

C26H33N5O3 (463.2583)

(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propan-2-yl-2-(2-pyridinylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide

C26H33N5O3 (463.2583)

(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propyl-1-(3-pyridinylmethyl)-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide

C26H33N5O3 (463.2583)

[(1S)-1-(cyclopropylmethyl)-2-[(2-fluorophenyl)methyl]-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol

C28H34FN3O2 (463.2635)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (9Z,12Z)-heptadeca-9,12-dienoate

C22H42NO7P (463.2699)

lysoPE 17:2

C22H42NO7P (463.2699)

1-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphoethanolamine

C22H42NO7P (463.2699)

lysophosphatidylcholine 14:2

C22H42NO7P (463.2699)

A lysophosphatidylcholine in which the remaining acyl group contains 14 carbons and 2 double bonds. If R1 is the acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is the acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.

LPC 14:2

C22H42NO7P (463.2699)

ST 27:7;O2;Gly

C29H37NO4 (463.2722)

16-benzyl-5,18-dihydroxy-9,14,15-trimethyl-5h,6h,7h,8h,9h,10h,12ah,15h,15ah,16h-oxacyclotetradeca[3,2-d]isoindol-2-one

C29H37NO4 (463.2722)

(3s,3ar,4s,6s,6as,10r,14s,17ar)-3-benzyl-1,6,14-trihydroxy-4,10-dimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h,12h,13h,14h-cyclotrideca[d]isoindol-17-one

C29H37NO4 (463.2722)

(5r,9r,12ar,15s,15as,16s,18as)-16-benzyl-5,18-dihydroxy-9,14,15-trimethyl-5h,6h,7h,8h,9h,10h,12ah,15h,15ah,16h-oxacyclotetradeca[3,2-d]isoindol-2-one

C29H37NO4 (463.2722)

(5r,9r,12as,15s,15as,16s,18ar)-16-benzyl-5,18-dihydroxy-9,14,15-trimethyl-5h,6h,7h,8h,9h,10h,12ah,15h,15ah,16h-oxacyclotetradeca[3,2-d]isoindol-2-one

C29H37NO4 (463.2722)

benzoylnapelline

C29H37NO4 (463.2722)

{"Ingredient_id": "HBIN017824","Ingredient_name": "benzoylnapelline","Alias": "NA","Ingredient_formula": "C29H37NO4","Ingredient_Smile": "NA","Ingredient_weight": "463.61","OB_score": "34.05649896","CAS_id": "198126-85-1","SymMap_id": "SMIT04655","TCMID_id": "NA","TCMSP_id": "MOL002410","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}